| Sep 2, 2026 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | SELL | 10.000K | $80.06 | $801K |
| Sep 1, 2026 | Yeu Elizabeth Lin | CHIEF MEDICAL OFFICER | SELL | 11.578K | $77.56 | $898K |
| Jun 17, 2026 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | SELL | 10.000K | $61.55 | $615K |
| Jun 15, 2026 | Jeffrey Farrow | SEE REMARKS | SELL-OPTIONS | 13.485K | $60.95 | $877K |
| Jun 15, 2026 | Katherine Goodrich | DIRECTOR | SELL | 2.954K | $62.08 | $183K |
| Jun 15, 2026 | PHD WILLIAM LINK | DIRECTOR | SELL | 12.500K | $62.12 | $776K |
| Mar 20, 2026 | Seshadri Neervannan | CHIEF OPERATING OFFICER | SELL | 2.989K | $66.75 | $200K |
| Mar 17, 2026 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | SELL | 12.274K | $68.36 | $839K |
| Mar 17, 2026 | Bryan Wahl | GENERAL COUNSEL | SELL | 12.440K | $68.36 | $850K |
| Mar 17, 2026 | Seshadri Neervannan | CHIEF OPERATING OFFICER | SELL | 11.324K | $68.21 | $772K |
| Mar 17, 2026 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | SELL | 13.056K | $68.36 | $893K |
| Mar 17, 2026 | Yeu Elizabeth Lin | CHIEF MEDICAL OFFICER | SELL | 1.144K | $68.36 | $78K |
| Mar 17, 2026 | Jeffrey Farrow | SEE REMARKS | SELL | 6.430K | $68.36 | $440K |
| Mar 17, 2026 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | SELL | 34.603K | $68.34 | $2.4M |
| Mar 16, 2026 | PHD WILLIAM LINK | DIRECTOR | SELL | 12.500K | $68.79 | $860K |